Silodosin — CAS 160970-54-7

Silodosin is a highly selective alpha-1A adrenoceptor antagonist indicated for the symptomatic treatment of benign prostatic hyperplasia. Its high selectivity for the alpha-1A receptor in the prostate minimizes cardiovascular side effects. Mediocon Inc manufactures GMP-certified Silodosin API at its Aurangabad facility.

• Benign prostatic hyperplasia (BPH)
• Lower urinary tract symptom relief
• Alpha-blocker therapy
• Urology formulations

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support